Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
302 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Completed Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin
22 Recruiting EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer
Conditions: Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M);   Breast Cancer Recurrent
Intervention: Biological: CAR-T cells recognizing EpCAM
23 Recruiting Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.
Conditions: Nasopharyngeal Neoplasms;   Mortality;   Quality of Life;   Complications
Interventions: Radiation: Hyperfractionated IMRT;   Radiation: Conventional Fraction IMRT
24 Completed The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
Condition: Nasopharyngeal Neoplasms
Intervention: Other: the number of circulating tumor cells
25 Completed Environmental and Genetic Determinants of NPC
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
26 Completed Taxotere + Cisplatin in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Docetaxel;   Drug: Cisplatin
27 Completed The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Radiation: IMRT
28 Unknown  Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
29 Enrolling by invitation A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: endostar;   Radiation: intensity modulated radiation;   Drug: cisplatin
30 Recruiting A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Conditions: Nasopharyngeal Neoplasms;   Salivary Gland Diseases;   Bone Marrow Diseases;   Mucositis
Interventions: Drug: Amifostine every-other-day regimen;   Drug: Amifostine everyday regimen
31 Active, not recruiting Family Study of Head and Neck Cancers in Taiwan
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
32 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
33 Active, not recruiting Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab;   Drug: placebo plus chemoradiotherapy
34 Completed Parotid-sparing IMRT for Nasopharyngeal Cancer
Conditions: Nasopharyngeal Cancers;   Intensity Modulated Radiotherapy With Chemotherapy
Intervention: Radiation: Intensity modulated radiotherapy with chemotherapy
35 Terminated Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
Condition: Nasopharyngeal Cancers
Intervention: Procedure: Induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy
36 Completed EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer;   EBV Infections
Interventions: Biological: EBV specific CTL Infusion;   Biological: Anti CD45 monoclonal antibody
37 Recruiting Screening for Nasopharyngeal Carcinoma in High Risk Populations
Conditions: Nasopharyngeal Cancer;   Screening
Intervention:
38 Completed Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Condition: Nasopharyngeal Carcinoma
Intervention:
39 Completed HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: interventional therapy
40 Completed A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Interventions: Drug: Capecitabine;   Drug: Cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years